Background Use of statin after an acute myocardial infarction (AMI) improves outcomes. However, it is debated whether receiving statin for primary prevention improves in-hospital outcomes when presenting with the first…
Background Patients presenting with ST-elevation myocardial infarction (STEMI) have different clinical outcomes based on their clinical baseline characteristics and presentation. This study was aimed to determine the importance of lesion…
Background This study assessed the probable synergistic effect of combination of intracoronary (IC) tirofiban and manual thrombectomy (MT) during primary percutaneous coronary intervention (pPCI) in patients with acute ST-elevation myocardial…
The treatment of STEMI using balloon angioplasty and stent is problematic because of potential distal embolization, microvascular plugging, decreased myocardial perfusion and higher mortality. Excimer laser coronary atherectomy (ELCA) can…
Background Prior studies have found an apparent paradox: the acute phase outcomes in smokers after acute myocardial infarction (MI) are superior to those of nonsmokers. Further, smoking is reported to…
Purpose Recent improvement in management of ST-elevation myocardial infarction (STEMI), and notably reduction of delays to coronary reperfusion, allowed a decrease of the incidence of complications. This study aims at…
Purpose For patients (pts) who present an acute myocardial infarction (STEMI), the benefit of PCI in culprit lesion is clearly demonstrated. Regarding this population, around 40% of pts had multivessel…
Background Left ventricular thrombus formation is a recognized complication of ST-elevation myocardial infarction (STEMI). Little information exists about the incidence of LV thrombus formation in the modern era of primary…
Background Retrospective data have shown that selective intracoronary administration of nitroprusside prior to percutaneous coronary intervention (PCI) is safe, prevents no or slow reflows and improves reperfusion of the infarcted…
Background Both high on-treatment platelet reactivity and periprocedural myocardial infarction (MI) are associated with adverse events following percutaneous coronary intervention (PCI). The optimal method of quantifying platelet reactivity remains controversial….
